• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

IRIDEX gets patents for Laserscope aesthetics

Article

Mountain View, CA-IRIDEX Corp. has completed its acquisition of San Jose, CA-based Laserscope's aesthetics business.

Mountain View, CA-IRIDEX Corp. has completed its acquisition of San Jose, CA-based Laserscope's aesthetics business.

The $26 million cash and stock deal, announced Nov. 30, gives IRIDEX four patents, a license to an additional nine Laserscope patents, and a license under Palomar hair removal patents. IRIDEX also acquired between $7.3 million and $9.5 million in net assets under the transaction, including accounts receivable from Laserscope.

IRIDEX said the acquisition should more than double its 2006 revenues of $36 million in 2007, anticipating that revenue for the full year 2007 should be about $75 million.

Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
© 2024 MJH Life Sciences

All rights reserved.